ARPO
Aerpio Pharmaceuticals, Inc.
Orbimed Advisors LLC bought $3.0M of Aerpio Pharmaceuticals, Inc.
Director and 10% owner
Bought$2,993,375
$3.85Price
777,500Shares
+18%Stake
What ARPO did for a copier
Prices for ARPO after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jun 28. Filed Mon, Jul 2. Not investment advice.